...
首页> 外文期刊>ChemMedChem >Synthesis of Bicyclic N-Arylmethyl-Substituted Iminoribitol Derivatives as Selective Nucleoside Hydrolase Inhibitors
【24h】

Synthesis of Bicyclic N-Arylmethyl-Substituted Iminoribitol Derivatives as Selective Nucleoside Hydrolase Inhibitors

机译:选择性核苷水解酶抑制剂双环N-芳甲基甲基取代的氨基核糖醇衍生物的合成

获取原文
获取原文并翻译 | 示例
           

摘要

The purine metabolism of Trypanosoma and Leishmania spp. provides a good target in the search for new selective drugs. Bi-cyclic N-arylmethyl-substituted iminoribitols were developed as inhibitors of T. vivax nucleoside hydrolase, a key enzyme of the purine salvage pathway. The obtained results and structure-ac-tivity data confirmed our model for inhibitor binding with a hy-drogen bond between a nitrogen atom of the nudeobase mimetic and the protonated Asp40 from the enzyme. This interaction depends on an optimal pK_α value, which can be influenced by the electronic properties of the substituents. These compounds are potent, selective inhibitors of nucleoside hydrolase and are inactive toward human nucleoside phosphorylase.
机译:锥虫和利什曼原虫属的嘌呤代谢。为寻找新的选择性药物提供了一个很好的目标。开发双环N-芳基甲基取代的亚氨基核糖醇作为间日疟原虫核苷水解酶(嘌呤挽救途径的关键酶)的抑制剂。获得的结果和结构活性数据证实了我们的抑制剂与裸碱基模拟物的氮原子和酶的质子化Asp40之间的氢键结合的抑制剂模型。这种相互作用取决于最佳的pK_α值,该值可能会受到取代基的电子特性的影响。这些化合物是核苷水解酶的有效选择性抑制剂,对人核苷磷酸化酶无活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号